News from the BioCity Campus

23rd biosaxony on site: "Cutting Edge - Innovations in medicine through cell and gene therapy"

The Industry association biosaxony invites together vfa bio, The VCI e. V. Northeast Regional Association and the  Center for Regenerative Therapies Dresden (CRTD)    23. biosaxony on site on the subject "Cutting Edge - Innovations in medicine through cell and gene therapy" am 01 December 2020 welcome. The event takes place virtual instead.

Advanced Therapy Medicinal Products (ATMP) are among the most promising treatment approaches for rare and as yet incurable diseases. In addition to gene therapeutics, ATMP also include cell therapeutics and biotechnologically processed tissue products. They contain either an active ingredient that includes a recombinant nucleic acid or modified cells that replace dysfunctional or defective cells or support processes in diseased tissue to regenerate missing or misdirected functions. In particular, patients suffering from severe hereditary and metabolic diseases, neurodegenerative diseases or cancer have high hopes for these innovative therapies.

The focus of the event is the dialogue between science and industry about the opportunities, risks and special features of cell and gene therapies.

More information and registration can be found here.

previous news

Spectaris: Access to reimbursement system for medical devices remains too complex

The way into the German reimbursement system for improved medical devices is still too complex and time-consuming, explain the four associations of the medical technology and diagnostics industry BVMed, Spectaris, VDGH and ZVEI.


Because of Corona: Liver transplant patient day on November 21st online only

This year's Liver Transplant Patient Day will take place online at the University Hospital Leipzig (UKL). "Have to take place", regret Prof. Dr. Daniel Seehofer, Head of the Division of Hepatobiliary Surgery and Visceral Transplantation, and Prof. Dr. Thomas Berg, head of the hepatology department at UKL. "Because the protection of our patients is our top priority."